Promising Results: TGR-63 Enhances Memory in Alzheimer's Mou

IGC Pharma, Inc. today announced the results of preclinical studies investigating its drug candidate TGR-63 as a treatment for Alzheimer's disease. The data demonstrated enhanced memory function in...

Related Keywords

Canada , United States , American , Ram Mukunda , Pharma Inc , Exchange Commission , Novel Object Recognition , Morris Water Maze , Discrimination Index , Looking Statements , Risk Factors , Annual Report , Quarterly Report ,